Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biopharma Stocks June 2017: BIO’s Rallying Cry Gets A Response

Executive Summary

In this month’s stock column, after the Nasdaq Biotech Index (NBI) shot up over 10% at end of June, Scrip focuses on the biopharma companies that propelled that surge. It looks as if investors have been influenced by the BIO Convention held in San Diego, the industry’s biggest forum for self-promotion.

Advertisement

Related Content

Portola's Bevyxxa Poised To Capture Niche Novel Anticoagulant Market
Clovis's Rubraca Leapfrogs Rivals In Ovarian Cancer As ARIEL3 Hits
Orphan Biosimilars: Developers See Big Prospects In Small Markets; Soliris Is One Target
Loxo's Larotrectinib Requires Paradigm-Change In Clinical Practice

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC099039

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel